NAHSV Healthlinko Private Limited has entered its second year of operations after completing a foundational first year marked by profitable growth, increasing patient demand and expanding international partnerships through its flagship healthcare platform, MediFyr.
Established in April 2025, the company was created to improve healthcare access through technology-led solutions that simplify how patients discover services, connect with providers and navigate medical needs. One year into operations, the company says early traction has reinforced the strength of its model and created a foundation for broader scale.
Through MediFyr, the company is currently supporting more than 2,000 patients every month, helping address healthcare access needs while strengthening support across treatment discovery and patient coordination. According to the company, growing adoption has contributed to ₹65 lakh in revenue generated in the last quarter of the previous financial year, reflecting strong momentum during its first year.
NAHSV Healthlinko stated these milestones were achieved without raising external funding, with the business operating as a bootstrapped and profitable enterprise. Management said this has allowed the company to prioritize sustainable expansion, operational discipline and long-term growth over capital-driven scaling.
The company added that its first year strategy focused not only on growth, but also on building resilient foundations — including technology development, partner relationships and scalable operating structures.
In addition to MediFyr, NAHSV Healthlinko has continued expanding a broader brand portfolio that includes Zerunio, WhatPregnant, HealthSetu and Unikorn, aligned with its strategy of developing a wider digital health ecosystem.
A major focus moving forward is the expansion of MediFyr’s international network. The company has already established hospital partnerships across Turkey, Egypt, Israel, Thailand, UAE and China, supporting the development of an early cross-border healthcare network and creating opportunities for deeper global engagement.
The company said these partnerships form part of a broader roadmap aimed at strengthening international patient pathways and expanding MediFyr’s reach into additional markets over time.
“Our first year has been about building credibility, creating momentum and laying strong operational foundations,” the company said in a statement. “As we move into year two, the focus is on expanding responsibly, strengthening partnerships and scaling the opportunities ahead.”
Year two priorities include expanding patient reach, increasing strategic partnerships, enhancing digital capabilities and strengthening the company’s presence across both domestic and international markets.
With profitable performance, growing patient demand and an expanding international network already in place, the company believes it is well positioned to pursue its next phase of growth.